BioRestorative Therapies Statistics Share Statistics BioRestorative Therapies has 7.98M
shares outstanding. The number of shares has increased by 8.45%
in one year.
Shares Outstanding 7.98M Shares Change (YoY) 8.45% Shares Change (QoQ) 8.45% Owned by Institutions (%) 3.37% Shares Floating 5.63M Failed to Deliver (FTD) Shares 545 FTD / Avg. Volume 0.36%
Short Selling Information The latest short interest is 152.05K, so 1.91% of the outstanding
shares have been sold short.
Short Interest 152.05K Short % of Shares Out 1.91% Short % of Float 2.27% Short Ratio (days to cover) 5.85
Valuation Ratios The PE ratio is -1.24 and the forward
PE ratio is -1.51.
BioRestorative Therapies's PEG ratio is
0.02.
PE Ratio -1.24 Forward PE -1.51 PS Ratio 27.69 Forward PS 6.5 PB Ratio 1.3 P/FCF Ratio -1.33 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for BioRestorative Therapies.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.97,
with a Debt / Equity ratio of 0.
Current Ratio 2.97 Quick Ratio 2.97 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $36.45K Profits Per Employee $-816.31K Employee Count 11 Asset Turnover 0.03 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 11.64% in the
last 52 weeks. The beta is -0.52, so BioRestorative Therapies's
price volatility has been lower than the market average.
Beta -0.52 52-Week Price Change 11.64% 50-Day Moving Average 1.57 200-Day Moving Average 1.71 Relative Strength Index (RSI) 51.2 Average Volume (20 Days) 151,025
Income Statement In the last 12 months, BioRestorative Therapies had revenue of 401K
and earned -8.98M
in profits. Earnings per share was -1.16.
Revenue 401K Gross Profit 372.93K Operating Income -11.56M Net Income -8.98M EBITDA -11.37M EBIT -11.56M Earnings Per Share (EPS) -1.16
Full Income Statement Balance Sheet The company has 547.89K in cash and 0 in
debt, giving a net cash position of 547.89K.
Cash & Cash Equivalents 547.89K Total Debt n/a Net Cash n/a Retained Earnings -155.68M Total Assets 8.52M Working Capital 3.93M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.23M
and capital expenditures -106.19K, giving a free cash flow of -8.34M.
Operating Cash Flow -8.23M Capital Expenditures -106.19K Free Cash Flow -8.34M FCF Per Share -1.07
Full Cash Flow Statement Margins Gross margin is 93%, with operating and profit margins of -2881.59% and -2239.25%.
Gross Margin 93% Operating Margin -2881.59% Pretax Margin -2239.25% Profit Margin -2239.25% EBITDA Margin -2834.45% EBIT Margin -2881.59% FCF Margin -2078.94%
Dividends & Yields BRTX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for BRTX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 27, 2021. It was a
backward
split with a ratio of 1:4000.
Last Split Date Oct 27, 2021 Split Type backward Split Ratio 1:4000
Scores Altman Z-Score -29.13 Piotroski F-Score 3
